Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Retained Earnings (2021 - 2025)

Medicinova (MNOV) has disclosed Retained Earnings for 8 consecutive years, with -$438.7 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings changed N/A to -$438.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$438.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$438.7 million for FY2025, N/A changed from the prior year.
  • Retained Earnings for Q4 2025 was -$438.7 million at Medicinova, down from -$126803.0 in the prior quarter.
  • The five-year high for Retained Earnings was -$95040.0 in Q1 2021, with the low at -$438.7 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$252.0 million, with a median of -$392.0 million recorded in 2021.
  • The sharpest move saw Retained Earnings crashed 347788.64% in 2024, then soared 99.97% in 2025.
  • Over 5 years, Retained Earnings stood at -$393.1 million in 2021, then fell by 2.82% to -$404.1 million in 2022, then soared by 99.97% to -$118090.0 in 2023, then plummeted by 358894.49% to -$423.9 million in 2024, then dropped by 3.49% to -$438.7 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$438.7 million, -$126803.0, and -$432.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.